Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

A class 4 drug alertAugust 17 2015

A class 4 drug alert is advising of a printing error found on blister strips in a batch of Teva’s pregabalin 75mg capsules.

The error appears on the foil backing, where one of the occurrences of the medicine’s strength says 25mg, and not 75mg. The correct strength appears elsewhere on the packing, carton and insert. An image issued with the drug alert shows the incorrect strength appearing in the bottom right hand corner of the pack.
 
The affected batch number is 01811 with expiry Dec2017 and was first distributed from July 15 2015.

Teva believes around a third of the blister strips in the batch are affected, which could typically mean one or two strips in a carton of 56 capsules are affected.

The MHRA has advised: “To ensure continuity of supply, affected stock will not be recalled. No further stock with this error will be released to the market, however.”

General enquires about the product should be addressed to Teva UK Customer Service Team on 0800 590502 and medical enquiries can be made on 0207 5407117.

Link:

MHRA alert    

Teva statement

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...